| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |